CME Information

Target Audience

This conference is designed for interventional cardiologists, cardiac and vascular surgeons, nurse practitioners and physician assistants, interventional radiologists and other healthcare professionals interested in the optimal practice of interventional and structural cardiovascular medicine.

Activity Purpose

Cardiovascular practice has never evolved more rapidly than today as cardiologists and surgeons collaborate to offer exciting new options for percutaneous and minimally invasive hybrid therapies. Arteries, valves, veins, infracting, hypertrophied myocardium and other anatomic sites are targets for intervention and symptom relief in a vast array of cardiovascular pathology including STEMI, unstable angina/non-STEMI, cardiogenic shock, aortic stenosis, mitral regurgitation, acute stroke, claudication and limb salvage, chronic valvular and perivalvular defects and many other conditions including adult congenital heart disease. This course will feature the cumulative wisdom of 17 academic centers with live case demonstrations, lectures, presentations and discussions of complex cases, debates between well-known interventionalists and surgeons and the opportunity for insightful audience participation and discussion. The national concern regarding appropriate selection for diagnostic studies and intervention will be addressed in detail. The conference will feature joint sessions as well as dedicated tracks for coronary and structural/peripheral intervention.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Review current tactics and emerging approaches toward the optimal practice of coronary, structural, and peripheral interventions
  • Discuss percutaneous and surgical management of complex coronary artery disease, including chronic total inclusions, cardiogenic shock, and cardiac arrest
  • Compare innovative strategies for the prevention and management of stent thrombosis and restenosis, including drug-eluting stents and balloons
  • Assess the latest developments in transcatheter aortic and mitral valve replacement and repair
  • Evaluate and manage microvascular and vasospastic disease
  • Appraise surgical and catheter-directed therapy for acute pulmonary embolism
  • Differentiate and select among FFR, IFR, IVUS and OCT to determine best application for the patient’s needs
  • Review developments in left atrial appendage occlusion therapies

Accreditation & Credit Designation

The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

This activity is approved for AMA PRA Category 1 Credit™.

2016 Commercial Support

EPIC-SEC 2016 was supported by educational grants from the following companies:

  • Abbott
  • Abiomed
  • AstraZeneca
  • Boston Scientific
  • Edwards Life Sciences
  • Gilead
  • Medicure
  • Medtronic
  • Merck
  • Philips Volcano
  • St. Jude Medical
  • The Medicines Company
  • Vascular Solutions

In-kind Support

  • Mentice